• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌的激素模式。II. 与内分泌治疗原发反应的相关性。

Hormonal pattern in prostatic cancer. II. Correlation with primary response to endocrine treatment.

作者信息

Adlercreutz H, Rannikko S, Kairento A L, Karonen S L

出版信息

Acta Endocrinol (Copenh). 1981 Dec;98(4):634-40.

PMID:7304086
Abstract

In 32 subjects with histologically and/or cytologically verified prostatic cancer the hormonal pattern was studied by assaying 18 plasma and urinary hormones or groups of hormones and relating the values to the response to endocrine treatment. Total orchidectomy (orchiepididymectomy) was performed on 9 patients, subcapsular orchidectomy on 13 patients and oestrogen therapy with Estradurin was given in 4 patients. Six patients had total orchidectomy followed by estrogen therapy. With few exceptions all values were within the normal range. The only significant exceptions were the high urinary oestrogen values and the low urinary oestrone + oestradiol/oestriol ratio observed as compared to healthy males working in a factory. No urinary hormone values or ratios of hormone values could be used for the prediction of prognosis in prostatic carcinoma patients. However, the ratios of plasma testosterone/oestradiol (T/Oe2) and testosterone/prolactin (T/Prl) were found to give good information with regard to the response to endocrine treatment. High values for one or both of these ratios meant a good response to treatment in all subjects without exception in this material. Subjects with both ratios low had a good response to endocrine treatment in 50% of the cases. No other plasma hormones measured were of any help prognostically. It is concluded that by measuring the T/Oe2 and T/Prl ratios it seems possible to select a group of patients with favourable primary response to endocrine treatment.

摘要

在32例经组织学和/或细胞学证实为前列腺癌的患者中,通过检测18种血浆和尿液激素或激素组来研究激素模式,并将这些值与内分泌治疗的反应相关联。9例患者接受了全睾丸切除术(睾丸附睾切除术),13例患者接受了包膜下睾丸切除术,4例患者接受了用苯甲酸雌二醇的雌激素治疗。6例患者先进行了全睾丸切除术,随后接受了雌激素治疗。除少数例外,所有值均在正常范围内。唯一显著的例外是,与在工厂工作的健康男性相比,观察到尿液雌激素值较高,尿液雌酮+雌二醇/雌三醇比值较低。没有任何尿液激素值或激素值比值可用于预测前列腺癌患者的预后。然而,发现血浆睾酮/雌二醇(T/Oe2)和睾酮/催乳素(T/Prl)的比值能提供有关内分泌治疗反应的良好信息。在该材料中,这两个比值中一个或两个比值较高意味着所有受试者对治疗均有良好反应,无一例外。两个比值均低的受试者中,50%对内分泌治疗有良好反应。所检测的其他血浆激素在预后方面均无帮助。结论是,通过测量T/Oe2和T/Prl比值,似乎有可能选出一组对内分泌治疗有良好初始反应的患者。

相似文献

1
Hormonal pattern in prostatic cancer. II. Correlation with primary response to endocrine treatment.前列腺癌的激素模式。II. 与内分泌治疗原发反应的相关性。
Acta Endocrinol (Copenh). 1981 Dec;98(4):634-40.
2
The effects of endocrine therapy on plasma steroids in prostatic carcinoma patients.
Endocrinologie. 1984 Jul-Sep;22(3):191-7.
3
Hormonal pattern in prostatic cancer. I. Correlation with local extent of tumour, presence of metastases and grade of differentiation.前列腺癌中的激素模式。I. 与肿瘤局部范围、转移情况及分化程度的相关性
Acta Endocrinol (Copenh). 1981 Dec;98(4):625-33. doi: 10.1530/acta.0.0980625.
4
Long-term effects of endocrine treatment on serum steroids in advanced prostatic carcinoma patients.
Invest Urol. 1980 Jan;17(4):328-31.
5
Single drug polyestradiol phosphate therapy in prostatic cancer.单药聚磷酸雌二醇治疗前列腺癌
Am J Clin Oncol. 1988;11 Suppl 2:S101-3.
6
Prognostic value of serial tissue prostate-specific antigen measurements during different hormonal treatments in prostate cancer patients.前列腺癌患者在不同激素治疗期间连续组织前列腺特异性抗原测量的预后价值。
Clin Cancer Res. 2000 May;6(5):1790-5.
7
[Clinical studies on endocrine therapy of prostatic carcinoma (1): Multivariate analyses of prognostic factors in patients with prostatic carcinoma given endocrine therapy].
Hinyokika Kiyo. 1990 Mar;36(3):275-84.
8
Prognostic significance of tissue prostate-specific antigen in endocrine-treated prostate carcinomas.组织前列腺特异性抗原在内分泌治疗的前列腺癌中的预后意义。
Clin Cancer Res. 2000 Jan;6(1):160-5.
9
Polyestradiol phosphate and ethinyl estradiol in treatment of prostatic carcinoma.聚磷酸雌二醇和炔雌醇治疗前列腺癌
Scand J Urol Nephrol Suppl. 1980;55:95-7.
10
Urinary oxalate excretion during anti-androgenic therapy.抗雄激素治疗期间的尿草酸排泄
Invest Urol. 1980 Sep;18(2):110-1.

引用本文的文献

1
Usefulness of preoperative serum testosterone as a predictor of extraprostatic extension and biochemical recurrence.术前血清睾酮作为前列腺外侵犯和生化复发预测指标的效用
Korean J Urol. 2012 Jan;53(1):9-13. doi: 10.4111/kju.2012.53.1.9. Epub 2012 Jan 25.
2
The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model.雄激素水平对多尺度数学模型中前列腺癌的进化影响。
Biol Direct. 2010 Apr 20;5:24. doi: 10.1186/1745-6150-5-24.
3
Circulating testosterone, prostatic nuclear androgen receptor and time to progression in patients with metastatic disease of the prostate treated by orchiectomy.
睾丸切除术治疗的前列腺转移性疾病患者的循环睾酮、前列腺核雄激素受体与疾病进展时间
Urol Res. 1989;17(2):99-102. doi: 10.1007/BF00262028.